IL312714A - DICKKOPF-1 variant antibodies and methods of use - Google Patents

DICKKOPF-1 variant antibodies and methods of use

Info

Publication number
IL312714A
IL312714A IL312714A IL31271424A IL312714A IL 312714 A IL312714 A IL 312714A IL 312714 A IL312714 A IL 312714A IL 31271424 A IL31271424 A IL 31271424A IL 312714 A IL312714 A IL 312714A
Authority
IL
Israel
Prior art keywords
dickkopf
methods
variant antibodies
antibodies
variant
Prior art date
Application number
IL312714A
Other languages
English (en)
Hebrew (he)
Original Assignee
Twist Bioscience Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Twist Bioscience Corp filed Critical Twist Bioscience Corp
Publication of IL312714A publication Critical patent/IL312714A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL312714A 2021-11-18 2022-11-17 DICKKOPF-1 variant antibodies and methods of use IL312714A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163280840P 2021-11-18 2021-11-18
US202163286522P 2021-12-06 2021-12-06
US202263374497P 2022-09-02 2022-09-02
US202263379634P 2022-10-14 2022-10-14
PCT/US2022/050322 WO2023091614A2 (en) 2021-11-18 2022-11-17 Dickkopf-1 variant antibodies and methods of use

Publications (1)

Publication Number Publication Date
IL312714A true IL312714A (en) 2024-07-01

Family

ID=86397718

Family Applications (1)

Application Number Title Priority Date Filing Date
IL312714A IL312714A (en) 2021-11-18 2022-11-17 DICKKOPF-1 variant antibodies and methods of use

Country Status (8)

Country Link
US (2) US12134656B2 (cg-RX-API-DMAC7.html)
EP (1) EP4433085A2 (cg-RX-API-DMAC7.html)
JP (1) JP2024542194A (cg-RX-API-DMAC7.html)
KR (1) KR20240101677A9 (cg-RX-API-DMAC7.html)
AU (1) AU2022390457A1 (cg-RX-API-DMAC7.html)
CA (1) CA3238160A1 (cg-RX-API-DMAC7.html)
IL (1) IL312714A (cg-RX-API-DMAC7.html)
WO (1) WO2023091614A2 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3131689A1 (en) 2019-02-26 2020-09-03 Twist Bioscience Corporation Variant nucleic acid libraries for glp1 receptor
CN115023440B (zh) 2019-09-23 2025-09-12 特韦斯特生物科学公司 结合CD3ε的抗体
US12091777B2 (en) 2019-09-23 2024-09-17 Twist Bioscience Corporation Variant nucleic acid libraries for CRTH2
AU2020400030B2 (en) 2019-12-09 2026-05-21 Twist Bioscience Corporation Variant nucleic acid libraries for adenosine receptors
CA3190667A1 (en) 2020-08-26 2022-03-03 Aaron Sato Methods and compositions relating to glp1r variants
WO2022159620A1 (en) 2021-01-21 2022-07-28 Twist Bioscience Corporation Methods and compositions relating to adenosine receptors
US12258406B2 (en) 2021-03-24 2025-03-25 Twist Bioscience Corporation Antibodies that bind CD3 Epsilon
EP4433085A2 (en) 2021-11-18 2024-09-25 Twist Bioscience Corporation Dickkopf-1 variant antibodies and methods of use
EP4490318A4 (en) 2022-03-07 2026-06-10 Twist Bioscience Corp METHYLATION-MEDIATED ADAPTER ELIMINATION ON NUCLEIC ACID SEQUENCES
EP4695287A1 (en) 2023-04-14 2026-02-18 Twist Bioscience Corporation Compositions and methods related to dkk1 binders

Family Cites Families (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037454A (en) 1996-11-27 2000-03-14 Genentech, Inc. Humanized anti-CD11a antibodies
US7608693B2 (en) 2006-10-02 2009-10-27 Regeneron Pharmaceuticals, Inc. High affinity human antibodies to human IL-4 receptor
EP2140261A4 (en) 2007-03-26 2010-06-16 Genizon Biosciences Inc METHODS AND AGENTS FOR ASSESSING INFLAMMATORY ABDOMINAL INFECTION AND TARGETS FOR TREATMENT
US20130090457A1 (en) 2008-10-31 2013-04-11 Janssen Biotech, Inc. Toll-Like Receptor 3 Antagonists for the Treatment of Metabolic and Cardiovascular Diseases
WO2010130832A2 (en) * 2009-05-15 2010-11-18 Ablynx N.V. Amino acid sequences directed against dickkopf-1 and polypeptides comprising the same for the treatment of diseases and disorders associated with bone loss and/or osteolytic lesions
WO2011119484A1 (en) 2010-03-23 2011-09-29 Iogenetics, Llc Bioinformatic processes for determination of peptide binding
CN104109207B (zh) 2013-04-17 2017-12-12 上海市肺科医院 肺靶向性抗肺泡表面活性蛋白a的纳米抗体及其制备方法
US20160297883A1 (en) 2013-12-04 2016-10-13 Innovative Targeting Solutions, Inc. G-protein coupled receptor agonists and methods
WO2016022557A1 (en) 2014-08-05 2016-02-11 Twist Bioscience Corporation Cell free cloning of nucleic acids
CA2975852A1 (en) 2015-02-04 2016-08-11 Twist Bioscience Corporation Methods and devices for de novo oligonucleic acid assembly
CA2975855C (en) 2015-02-04 2025-09-23 Twist Bioscience Corporation SYNTHETIC GENE COMPOSITIONS AND ASSEMBLY METHODS
WO2016172377A1 (en) 2015-04-21 2016-10-27 Twist Bioscience Corporation Devices and methods for oligonucleic acid library synthesis
US20160333340A1 (en) 2015-05-11 2016-11-17 Twist Bioscience Corporation Compositions and methods for nucleic acid amplification
KR20180050411A (ko) 2015-09-18 2018-05-14 트위스트 바이오사이언스 코포레이션 올리고핵산 변이체 라이브러리 및 그의 합성
WO2017053450A1 (en) 2015-09-22 2017-03-30 Twist Bioscience Corporation Flexible substrates for nucleic acid synthesis
EP3384077A4 (en) 2015-12-01 2019-05-08 Twist Bioscience Corporation FUNCTIONALIZED SURFACES AND MANUFACTURE THEREOF
WO2017214574A1 (en) 2016-06-10 2017-12-14 Twist Bioscience Corporation Systems and methods for automated annotation and screening of biological sequences
CN110088281A (zh) 2016-08-03 2019-08-02 特韦斯特生物科学公司 用于多核苷酸合成的纹理化表面
WO2018038772A1 (en) 2016-08-22 2018-03-01 Twist Bioscience Corporation De novo synthesized nucleic acid libraries
EP4664304A3 (en) 2016-09-21 2026-01-21 Atlas Data Storage, Inc. Nucleic acid based data storage
AU2017363204B2 (en) 2016-11-18 2022-12-08 Twist Bioscience Corporation Polynucleotide libraries having controlled stoichiometry and synthesis thereof
GB2573069A (en) 2016-12-16 2019-10-23 Twist Bioscience Corp Variant libraries of the immunological synapse and synthesis thereof
WO2018156792A1 (en) 2017-02-22 2018-08-30 Twist Bioscience Corporation Nucleic acid based data storage
CA3056388A1 (en) 2017-03-15 2018-09-20 Twist Bioscience Corporation Variant libraries of the immunological synapse and synthesis thereof
AU2018234624B2 (en) 2017-03-15 2023-11-16 Twist Bioscience Corporation De novo synthesized combinatorial nucleic acid libraries
WO2018231864A1 (en) 2017-06-12 2018-12-20 Twist Bioscience Corporation Methods for seamless nucleic acid assembly
IL271205B2 (en) 2017-06-12 2025-02-01 Twist Bioscience Corp Methods for assembling continuous nucleic acids
CN111566125A (zh) 2017-09-11 2020-08-21 特韦斯特生物科学公司 Gpcr结合蛋白及其合成
CN111565834B (zh) 2017-10-20 2022-08-26 特韦斯特生物科学公司 用于多核苷酸合成的加热的纳米孔
US20200299684A1 (en) 2017-10-27 2020-09-24 Twist Bioscience Corporation Systems and methods for polynucleotide scoring
IL312616B2 (en) 2018-01-04 2025-08-01 Twist Bioscience Corp Dna-based digital information storage
EP3814497A4 (en) 2018-05-18 2022-03-02 Twist Bioscience Corporation POLYNUCLEOTIDES, REAGENTS AND METHODS FOR NUCLEIC ACID HYBRIDIZATION
EP3902816A4 (en) 2018-12-26 2022-09-14 Twist Bioscience Corporation HIGH-PRECISION DE NOVO POLYNUCLEOTIDE SYNTHESIS
CN113728100A (zh) 2019-02-25 2021-11-30 特韦斯特生物科学公司 用于下一代测序的组合物和方法
CA3131689A1 (en) 2019-02-26 2020-09-03 Twist Bioscience Corporation Variant nucleic acid libraries for glp1 receptor
KR20210144698A (ko) 2019-02-26 2021-11-30 트위스트 바이오사이언스 코포레이션 항체 최적화를 위한 변이 핵산 라이브러리
EP3987019A4 (en) 2019-06-21 2023-04-19 Twist Bioscience Corporation Barcode-based nucleic acid sequence assembly
US12091777B2 (en) 2019-09-23 2024-09-17 Twist Bioscience Corporation Variant nucleic acid libraries for CRTH2
CN115023440B (zh) 2019-09-23 2025-09-12 特韦斯特生物科学公司 结合CD3ε的抗体
AU2020400030B2 (en) 2019-12-09 2026-05-21 Twist Bioscience Corporation Variant nucleic acid libraries for adenosine receptors
BR112022021780A2 (pt) 2020-04-27 2023-03-07 Twist Bioscience Corp Bibliotecas de ácido nucléico variantes para coronavírus
EP4179001A4 (en) 2020-07-07 2024-07-10 Twist Bioscience Corporation DEVICES AND METHODS FOR LIGHT ORIENTATION POLYMER SYNTHESIS
US20220106586A1 (en) 2020-08-25 2022-04-07 Twist Bioscience Corporation Compositions and methods for library sequencing
CA3190667A1 (en) 2020-08-26 2022-03-03 Aaron Sato Methods and compositions relating to glp1r variants
US12534494B2 (en) 2020-08-28 2026-01-27 Twist Bioscience Corporation Devices and methods for synthesis
WO2022076326A1 (en) 2020-10-05 2022-04-14 Twist Bioscience Corporation Hybridization methods and reagents
EP4229210A4 (en) 2020-10-19 2025-01-08 Twist Bioscience Corporation METHOD FOR THE SYNTHESIS OF OLIGONUCLEOTIDES USING BOUND NUCLEOTIDES
WO2022087293A1 (en) 2020-10-22 2022-04-28 Twist Bioscience Corporation Methods and systems for detecting coronavirus
WO2022093811A1 (en) 2020-10-26 2022-05-05 Twist Bioscience Corporation Libraries for next generation sequencing
US20220135690A1 (en) 2020-11-03 2022-05-05 Twist Bioscience Corporation Methods and compositions relating to chemokine receptor variants
WO2022159620A1 (en) 2021-01-21 2022-07-28 Twist Bioscience Corporation Methods and compositions relating to adenosine receptors
WO2022178137A1 (en) 2021-02-19 2022-08-25 Twist Bioscience Corporation Libraries for identification of genomic variants
US20220323924A1 (en) 2021-03-24 2022-10-13 Twist Bioscience Corporation Electrochemical polynucleotide synthesis
WO2022204309A1 (en) 2021-03-24 2022-09-29 Twist Bioscience Corporation Variant nucleic acid libraries for tigit
US12258406B2 (en) 2021-03-24 2025-03-25 Twist Bioscience Corporation Antibodies that bind CD3 Epsilon
CA3214947A1 (en) 2021-04-09 2022-10-13 Twist Bioscience Corporation Libraries for mutational analysis
WO2022235584A1 (en) 2021-05-03 2022-11-10 Twist Bioscience Corporation Variant nucleic acid libraries for glycans
US20220356468A1 (en) 2021-05-03 2022-11-10 Twist Bioscience Corporation Variant nucleic acid libraries for ion channels
WO2022271884A2 (en) 2021-06-22 2022-12-29 Twist Bioscience Corporation Methods and compositions relating to covid antibody epitopes
WO2023023183A2 (en) 2021-08-17 2023-02-23 Twist Bioscience Corporation Sars-cov-2 antibodies and related compositions and methods of use
WO2023023190A2 (en) 2021-08-17 2023-02-23 Twist Bioscience Corporation Single domain antibodies for sars-cov-2
WO2023023285A2 (en) 2021-08-19 2023-02-23 Twist Bioscience Corporation Methods and compositions relating to covalently closed nucleic acids
KR20240101595A (ko) 2021-10-18 2024-07-02 트위스트 바이오사이언스 코포레이션 연속 서열분석에 관한 방법 및 조성물
WO2023076419A2 (en) 2021-10-27 2023-05-04 Twist Bioscience Corporation Sars-cov-2 antibodies and methods of use
WO2023076420A2 (en) 2021-10-27 2023-05-04 Twist Bioscience Corporation Multispecific sars-cov-2 antibodies and methods of use
US12697597B2 (en) 2021-11-01 2026-08-04 Twist Bioscience Corporation Methods for polynucleotide synthesis
WO2023091609A2 (en) 2021-11-18 2023-05-25 Twist Bioscience Corporation Cytokine variant antibodies and methods of use
EP4433085A2 (en) 2021-11-18 2024-09-25 Twist Bioscience Corporation Dickkopf-1 variant antibodies and methods of use
EP4441099A2 (en) 2021-12-01 2024-10-09 Twist Bioscience Corporation Neuropilin-1 variant antibodies and methods of use
WO2023191858A2 (en) 2021-12-08 2023-10-05 Twist Bioscience Corporation Nanoelectric devices and use thereof
WO2023114432A2 (en) 2021-12-17 2023-06-22 Twist Bioscience Corporation Compositions and methods for detection of variants
US12325739B2 (en) 2022-01-03 2025-06-10 Twist Bioscience Corporation Bispecific SARS-CoV-2 antibodies and methods of use
WO2023154533A2 (en) 2022-02-14 2023-08-17 Twist Bioscience Corporation Combinatorial dna assembly for multispecific antibodies
EP4490318A4 (en) 2022-03-07 2026-06-10 Twist Bioscience Corp METHYLATION-MEDIATED ADAPTER ELIMINATION ON NUCLEIC ACID SEQUENCES
CA3247327A1 (en) 2022-04-01 2023-10-05 Twist Bioscience Corporation BANKS FOR METHYLATION ANALYSIS
AU2023249258A1 (en) 2022-04-07 2024-12-05 Twist Bioscience Corporation Substrate cleavage for nucleic acid synthesis
JP2025515452A (ja) 2022-04-21 2025-05-15 ツイスト バイオサイエンス コーポレーション Dnaデータ・ストレージのためのコーデック

Also Published As

Publication number Publication date
EP4433085A2 (en) 2024-09-25
JP2024542194A (ja) 2024-11-13
US20230312749A1 (en) 2023-10-05
WO2023091614A2 (en) 2023-05-25
CA3238160A1 (en) 2023-05-25
KR20240101677A (ko) 2024-07-02
KR20240101677A9 (ko) 2025-12-10
US20250075004A1 (en) 2025-03-06
AU2022390457A1 (en) 2024-06-20
US12134656B2 (en) 2024-11-05
WO2023091614A3 (en) 2023-11-02

Similar Documents

Publication Publication Date Title
GB202019709D0 (en) Anti-Coronavirus antibodies and methods of use
ZA202004735B (en) Anti-pd-1 antibodies and methods of treatment
IL278821A (en) Anti-SIRPA antibodies and methods of using them
IL276731A (en) Antibodies against CD73 and methods of using them
SG11202108734VA (en) Anti-trem2 antibodies and methods of use thereof
SG11202010909RA (en) Anti-msr1 antibodies and methods of use thereof
IL279648A (en) Anti-SIRP-in-cell 1 antibodies and methods of using them
ZA201906731B (en) Anti-sortilin antibodies and methods of use thereof
IL289952A (en) Anti-ms4a4a antibodies and methods of using them
IL287282A (en) Anti-mertk antibodies and methods of using them
KR20240101677A9 (ko) Dickkopf-1 변이체 항체 및 사용 방법
IL290741A (en) Antibodies against cd-96 and methods of using them
IL316368A (en) Anti-TL1A antibodies and methods of using them
SI4200018T1 (sl) Protitelesa proti-PAR-2 in postopki njihove uporabe
IL277212A (en) Anti-KLK5 antibodies and methods of use
IL298668B1 (en) Anti-CD200R1 antibodies and methods of using them
IL280338A (en) Anti-SIGLEC-5 antibodies and methods of using them
IL288886A (en) Antibodies and methods of use
IL291461A (en) Anti-alpha-synuclein antibodies and methods of using them
IL283884A (en) Antibodies against il-36 and methods of using them
IL279227A (en) Anti-SIGLEC-7 antibodies and methods of using them
IL315845A (en) Anti-dectin-1 antibodies and methods of using them
ZA202105152B (en) Anti-elastin antibodies and methods of use
GB201818477D0 (en) Tissue plasminogen activator antibodies and method of use thereof
IL318694A (en) Antibodies against CCR8 and methods of using them